Windlas Biotech Limited (WINDLAS.NS)
INR 1050.0
(-0.63%)
INR 1050.0
(-0.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.26 Billion INR | 18.38% |
| 2022 | 5.28 Billion INR | 7.73% |
| 2021 | 4.91 Billion INR | 65.81% |
| 2020 | 2.96 Billion INR | -12.52% |
| 2019 | 3.38 Billion INR | 13.52% |
| 2018 | 2.98 Billion INR | 2.86% |
| 2017 | 2.89 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 6.26 Billion INR | 18.38% |
| 2023 Q2 | 5.7 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 6.26 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 5.28 Billion INR | 7.73% |
| 2022 Q4 | 5.28 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 5.18 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 4.91 Billion INR | 65.81% |
| 2021 Q4 | 4.91 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 4.62 Billion INR | 0.0% |
| 2020 FY | 2.96 Billion INR | -12.52% |
| 2020 Q4 | 2.96 Billion INR | -6.26% |
| 2020 Q3 | 3.15 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 3.38 Billion INR | 0.0% |
| 2019 FY | 3.38 Billion INR | 13.52% |
| 2018 FY | 2.98 Billion INR | 2.86% |
| 2017 FY | 2.89 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Sigachi Industries Limited | 6.94 Billion INR | 9.789% |
| Ind-Swift Limited | 6.54 Billion INR | 4.319% |
| Bajaj HealthCare Limited | 7.65 Billion INR | 18.157% |
| Sakar Healthcare Limited | 3.88 Billion INR | -61.12% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 98.611% |
| Innova Captab Limited | 13.2 Billion INR | 52.592% |
| Divi's Laboratories Limited | 154.7 Billion INR | 95.952% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 41.912% |
| Morepen Laboratories Limited | 12.93 Billion INR | 51.577% |
| Mankind Pharma Limited | 119.63 Billion INR | 94.766% |
| Sequent Scientific Limited | 15.4 Billion INR | 59.347% |
| Wanbury Limited | 3.43 Billion INR | -82.305% |
| Laurus Labs Limited | 83.87 Billion INR | 92.534% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 71.42% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 78.031% |
| Alembic Limited | 23.28 Billion INR | 73.11% |
| Hikal Limited | 24.87 Billion INR | 74.822% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 90.285% |
| Neuland Laboratories Limited | 18.32 Billion INR | 65.829% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 84.322% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 95.639% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 72.099% |
| Themis Medicare Limited | 5.66 Billion INR | -10.556% |
| RPG Life Sciences Limited | 5.12 Billion INR | -22.098% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 97.861% |
| Lupin Limited | 239.97 Billion INR | 97.391% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -70.688% |
| Wockhardt Limited | 76.49 Billion INR | 91.813% |
| Vaishali Pharma Limited | 799.55 Million INR | -683.191% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 75.748% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -188.471% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 94.578% |
| FDC Limited | 24.68 Billion INR | 74.628% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 98.384% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -160.852% |
| Eris Lifesciences Limited | 70.48 Billion INR | 91.116% |
| Venus Remedies Limited | 6.26 Billion INR | 0.1% |
| ZIM Laboratories Limited | 4.46 Billion INR | -40.147% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 48.412% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -516.277% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 76.785% |
| Shilpa Medicare Limited | 30.93 Billion INR | 79.755% |
| Albert David Limited | 4.97 Billion INR | -25.746% |
| Ajanta Pharma Limited | 46.38 Billion INR | 86.499% |
| Hester Biosciences Limited | 6.62 Billion INR | 5.457% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 72.219% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 73.314% |
| Gufic Biosciences Limited | 10.92 Billion INR | 42.684% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 21.168% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -105.319% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -87.811% |
| Granules India Limited | 55.2 Billion INR | 88.658% |
| Aarti Drugs Limited | 24.32 Billion INR | 74.255% |
| Bal Pharma Limited | 3.2 Billion INR | -95.452% |
| Alkem Laboratories Limited | 155.74 Billion INR | 95.979% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.267% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | 10.579% |
| Medicamen Biotech Limited | 2.94 Billion INR | -112.617% |
| Unichem Laboratories Limited | 31.69 Billion INR | 80.242% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -324.024% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -1230.013% |
| Valiant Laboratories Limited | 3.42 Billion INR | -82.734% |
| Orchid Pharma Limited | 15.53 Billion INR | 59.7% |
| Medico Remedies Limited | 961.95 Million INR | -550.974% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 46.253% |
| Ipca Laboratories Limited | 111.01 Billion INR | 94.359% |
| Brooks Laboratories Limited | 904.45 Million INR | -592.358% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -54.747% |
| Piramal Enterprises Limited | 826.05 Billion INR | 99.242% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 95.842% |
| NATCO Pharma Limited | 69.06 Billion INR | 90.933% |
| Suven Life Sciences Limited | 2.84 Billion INR | -119.796% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -251.456% |
| Strides Pharma Science Limited | 58.39 Billion INR | 89.277% |
| Indoco Remedies Limited | 21.44 Billion INR | 70.803% |
| Alpa Laboratories Limited | 1.82 Billion INR | -242.898% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -315.067% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -21.584% |